Stroke prophylaxis with Apixaban in CKD5 patients with atrial fibrillation (SACK)

200M kr SEK

Funder	Swedish Research Council
Recipient Organization	Stockholm County Council
Country	Sweden
Start Date	Jan 01, 2022
End Date	Dec 31, 2025
Duration	1,460 days
Number of Grantees	11
Roles	Co-Investigator; Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2021-00235_VR`

Grant Description

Atrial fibrillation (AF) is a frequent cardiovascular complication in people with chronic kidney disease (CKD), which more than double the risk of stroke.

Currently there is a knowledge gap in the efficacy and safety of all anticoagulant treatments in people with CKD stage 5 (glomerular filtration rate